SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Save The World Air Inc. (ZERO) -- Ignore unavailable to you. Want to Upgrade?


To: Q. who wrote (240)7/24/2000 4:36:45 PM
From: Boquacious  Respond to of 445
 
Monday July 24, 10:08 am Eastern Time
Company Press Release
SOURCE: Centre Capital Corp.
Centre Capital Corp. Form 8-K/A
FORT WORTH, Texas, July 24 /PRNewswire/ -- Centre Capital Corp. (OTC Bulletin Board: CCCX - news; cccx.net) published the body of its form 8-K/A. Full text and all filings are available at freeedgar.com.

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K/A
AMENDMENT NO. 1

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported): JULY 3, 2000

CENTRE CAPITAL CORPORATION
(Exact Name of Registrant as Specified in Its Charter)

STATE OF NEVADA
(State or Other Jurisdiction of Incorporation)

000-25845 87-0385103
(Commission File No.) (I.R.S. Employer Identification No.)

2619 GRAVEL STREET
FORT WORTH, TEXAS 76118
(Address of Principal Executive Offices)

(817) 595-0919
(Registrant's Telephone Number, Including Area Code)

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.

(b) Pro forma financial information. The pro forma financial information
required by Regulation S-X is attached hereto.

The Registrant believes that this report contains forward-looking statements, including statements regarding, among other items, its future plans and growth strategies and anticipated trends in the industry in which it operates. These forward-looking statements are based largely on the Registrant's expectations and are subject to a number of risks and uncertainties, many of which are beyond its control. Actual results could differ materially from these forward-looking statements as a result of the factors described in this report, including, among others, regulatory or economic influences. In light of these risks and uncertainties, the forward-looking information contained in this report may not transpire or prove to be accurate. The inclusion of that information should not be regarded as a representation by the Registrant or any other person that its objectives and plans will be achieved.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CENTRE CAPITAL CORPORATION

Date: July 20, 2000 By /s/ Karl F. Jacobs
Karl F. Jacobs, Chairman

CENTRE CAPITAL CORPORATION
Condensed Balance Sheet
(unaudited) Forecast

Forecast

Current Assets 13,133,188
Property 593,509
Other Assets 11,307,843

Total Assets $25,034,540

Current Liabilities 567,892
Common Stock 17,903
Additional Paid in Capital 12,298,167
Retained earnings 12,150,578

Total Liabilities and
Stockholders Capital $25,034,540

Condensed Statement of Operations
For the year ended June 30, 2001
(unaudited)

Forecast

Revenue $41,588,809
Cost of Sales 18,777,574
Operating Expenses 1,486,966
Other expenses 16,000

Net Income before tax 21,326,269

Provision for income tax 8,559,133
Net Income after tax $12,767,136

Weighted average shares 17,902,756
Earnings per share $ .71

CENTRE CAPITAL CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
June 30, 2001 (Forecast)

NOTE A -- UNAUDITED CONDENSED FINANCIAL STATEMENTS:

The accompanying condensed financial statements were prepared by management without audit. These financial statements have not been examined by independent public accountants. These financials statements should be read in conjunction with the Form 10-KSB for the initial eight months ended September 30, 1999.

NOTE B -- SUMMARY OF SIGNIFICANT FORECAST ASSUMPTIONS:

This financial forecast presents, to the best of management's knowledge and belief, the Company's expected financial position, results of operations, and cash flows for the forecast period. Accordingly, the forecast reflects management's judgment as of July 17, 2000, the date of this forecast, of the expected conditions and its expected course of action. The assumptions disclosed herein are those that management believes are significant to the forecast. There will usually be differences between the forecasted and actual results, because events and circumstances frequently do not occur as expected, and those differences may be material.

Other Assets:

The zeolite purchase asset was recorded at the contract amount per the Zeolite Purchase Agreement as an other asset in the amount of $11,307,428. The common stock and additional paid in capital were increased accordingly due to stock being issued as consideration. The number of newly issued shares of the Company's $.001 par value common stock is 1,000,000 shares.

Sales:

Management developed the gross sales forecast by listing forecasted unit sales for each product or group of products. Zeolite sales are forecast for the year at $1,728,000. Revenues from the royalty agreements are forecast for the year at $4,230,751. Forecast sales from existing product lines are for $3,097,529 for the year. Other existing product sales were forecast in the amount of $36,159,750 for the 12 months ended June 30, 2001 due to increased promotional and advertising efforts plus endorsements. Some product sales for the forecast year are forecast at 150 times over the first eight months ended September 30, 1999.

Royalties:

Royalty revenue was based on fixed percentages in accordance with the royalty contracts and forecasted sales for products and services. One royalty contract agreement calls for the Company to receive 7.5 percent of gross sales from a network of chiropractors and doctors. Revenue from this contract is estimated at $3,131,851.

The second royalty contract agreement is with Benex Group, Ltd. and calls for the Company to receive 5 percent of gross sales of health plans and products. Revenue from this contract is estimated at $1,099,100 for the forecast year ending June 30, 2001.

Cost of Sales:

Commissions are forecast as a function of sales, using historical and anticipated factors ranging from 20% to 50% for the year ending June 30, 2001. Commissions for the sale of products are estimated at $8,780,715 for the forecast year. Commissions for the sale of zeolite is estimated at $465,000 for the forecast year. Other cost of sales forecast such as inventory are forecast at factors from 10% to 22% of sales and are estimated at $9,519,441 for the forecast year.

Advertising:

Assumptions for advertising expense for the forecast year were computed at $550,000 and were based on proposed contracts to produce and broadcast infomercials for both a flat fee and percentage of sale fee arrangements.

General and Administrative

Other operating expenses including administrative expenses are based on prior experience of the Company adjusted for anticipated increases to volume and other business activity and are forecast at $900,000 for the year ending June 30, 2001.

CENTRE CAPITAL CORPORATION
PRO FORMA FINANCIAL STATEMENTS
(unaudited)
The Registrant's unaudited pro forma financial statements give effect to the acquisition of 58,285.71 tons of zeolite minerals and two royalty agreements, as if these transactions had occurred, for balance sheet purposes, on March 31, 2000 and, for statement of operations purposes, on October 1, 1999. These unaudited pro forma financial statements should be read in conjunction with the Registrant's financial statements and notes thereto appearing in the Form 10-KSB. The pro forma information is not necessarily indicative of the results that would have been reported had such events actually occurred on the dates specified, nor is it indicative of the Registrant's future results.

Condensed Pro forma Balance Sheet
(unaudited)
March 31, 2000
Historical Adjustments Pro Forma

Current Assets 66,962 50,000 116,962
Property 593,509 --- 593,509
Other Assets 415 11,307,428 11,307,843

Total Assets $660,886 $11,357,428 $12,018,314

Current Liabilities 1,440,175 (958,626) 481,549
Common Stock 10,042 1,000 11,042
Additional Paid in Capital 170,391 11,306,428 11,476,819
(Accumulated deficit)
Retained Earnings (959,722) 1,008,626 48,904

Total Liabilities and
Stockholders' Equity $660,886 $11,357,428 $12,018,314

Condensed Pro forma Statement of Operations
(unaudited)
Six Months ended March 31, 2000

Historical Adjustments Pro Forma

Revenue $ 221,662 $1,234,149 $ 1,455,811
Cost of Sales 175,287 75,000 250,287
Operating Expenses 373,539 136,707 510,246
Other expenses 16,000 --- 16,000
Net Income (Loss) before tax (343,164) 1,022,442 679,278
Provision for income tax --- 13,816 13,816
Net Income (Loss) after tax (343,164) 1,008,626 665,462

Weighted average shares 10,042,052 1,000,000 11,042,052
Earnings(loss) per share ($.03) $.09 $.06

CENTRE CAPITAL CORPORATION
NOTES TO PRO FORMA FINANCIAL STATEMENTS
(unaudited)

Note A -- Nature of Acquisition:

The Registrant acquired 58,285.71 tons of paid up zeolite from Equitable Assets Incorporated, a Belize corporation. This acquisition was valued at $11,307,428 pursuant to a Zeolite Purchase Agreement. The consideration paid by the Registrant for the zeolite was 1,000,000 shares of the Registrant's restricted common stock with a par value of $0.001 per share.

Note B -- Adjustments for acquisition of zeolite:
Balance Sheet:
The zeolite is classified as an other asset in the amount of $11,307,428.

There is a corresponding amount representing the issuance of the Registrant's
restricted common stock and additional paid in capital. Proceeds from the
entire operation is used to reduce current liabilities in the amount of
$958,626 and increase in current assets of $50,000.
Statement of Operations:

There is an assumption of increased sales in the amount of $500,000 for zeolite sales and $734,149 for royalty revenues for the six months ended March 31, 2000. Related cost of sales in the amount of $75,000 and administrative expenses in the amount of $136,707 have resulted in an increased net income before tax in the amount of $1,022,442.

Note C -- License delivery and royalty agreement:

The Registrant entered into license and royalty agreement with a network of physicians and chiropractors for Arthritis Relief Plus, a patented arthritis treatment. The agreement calls for a 7% royalty of gross sales of product sold by the members of the network to be paid to the Registrant.

Note D -- Adjustments for proceeds from royalty:
Statement of Operations:
Royalty income in the amount of 734,149 is adjusted for the six month

period ended March 31, 2000 and related administrative expenses in the amount
of $37,000.
Note E -- Royalty Interest:

The Registrant acquired a 5 percent interest in the gross revenues of Benex Group, Ltd. of Houston Texas. Benex Group, Ltd is a health benefit and products consolidation.

Note F -- Income Tax:

Income tax has been calculated based on the actual historical loss of $343,164 and a loss carryforward in the amount of $616,558 offset by current year earnings.

Centre Capital Corp. continually seeks new cutting edge products in order to broaden its line of product offerings. Centre is also seeking accretive acquisitions in distribution and marketing, its areas of core competence.

SAFE HARBOR STATEMENT: Certain statements in this news release may constitute ``forward looking'' information within the meaning of the Private Securities Litigation Reform Act of 1995. Such Forward looking statement involve risk and uncertainties that could cause actual results to differ materially from those set forth or implied by such forward statements. Forward Looking Statements: All statements other than statements of historical fact in this release are forward looking statements as a result of certain factors including, but not limited to the effect of business and economic conditions; the impact of competitive products and pricing; and capacity and supply constraints or difficulties. Such statements reflect the current views of the company with respect to future events and are subject to these and other risks and uncertainties and assumptions relation to the operations, results of operations, growth strategy and liquidity of the Company.

SOURCE: Centre Capital Corp.

Email this story - View most popular stories emailed



To: Q. who wrote (240)7/24/2000 4:39:27 PM
From: Boquacious  Read Replies (1) | Respond to of 445
 
Company Press Release
SOURCE: Centre Capital Corp.
Centre Capital's ARTHRITIS RELIEF PLUS to Be Featured on the Lori Kramer Show
FORT WORTH, Texas, July 24 /PRNewswire/ -- Centre Capital Corp. (OTC Bulletin Board: CCCX - news; cccx.net) announced today that Mr. Peter Anderson will appear live on the Lori Kramer show, Wednesday July 26, 2000 @ 2:15 PM (EST) to talk about their FDA listed product, Arthritis Relief Plus. The Lori Kramer show is heard on EYADA.com, the only radio network on the internet.

The studio hotline No. for Peter Anderson's interview with Lori Kramer is 1-877-392-3299.

Mr. Anderson will appear on the show at 2:15 (EST) to discuss their FDA Listed Arthritis treatment, ARTHRITIS RELIEF PLUS.

This amazing treatment has been used by over 100,000 people in the U.S. and around the world. ARTHRITIS RELIEF PLUS does more than treat the symptoms, it arrests the condition, and people are living pain free. ARTHRITIS RELIEF PLUS through independent studies under FDA guidelines showed that over 90% of those receiving ARP experienced relief of pain and stiffness, with no side effects. ARP treats: Osteoarthritis, Spondylitis, Rheumatoid Arthritis, Frozen Shoulder, and Calcaneal Spurs.

This is a 30 day treatment, that is available to the public.

As part of an effort to centralize operations, Centre Capital has moved its corporate headquarters to 2619 Gravel Road. Fort Worth, Texas 76118. The main phone number is 817-595-0919.

Centre Capital Corp. continually seeks new cutting edge products in order to broaden its line of product offerings. Centre is also seeking accretive acquisitions in distribution and marketing, its areas of core competence.

SAFE HARBOR STATEMENT: Certain statements in this news release may constitute ``forward looking'' information within the meaning of the Private Securities Litigation Reform Act of 1995. Such Forward looking statement involve risk and uncertainties that could cause actual results to differ materially from those set forth or implied by such forward statements. Forward Looking Statements: All statements other than statements of historical fact in this release are forward looking statements as a result of certain factors including, but not limited to the effect of business and economic conditions; the impact of competitive products and pricing; and capacity and supply constraints or difficulties. Such statements reflect the current views of the company with respect to future events and are subject to these and other risks and uncertainties and assumptions relation to the operations, results of operations, growth strategy and liquidity of the Company.

CONTACT: NEAL PUBLIC RELATIONS TEL - 714 848-8481
Roger Neal or Lynn Neal FAX - 714 848-9043
Toll Free 877 961-2229
Britt Brooks 713 334-8230

SOURCE: Centre Capital Corp.

Email this story - View most popular stories emailed

--------------------------------------------------------------------------------
More Quotes and News: Centre Capital Corp (OTC BB:CCCX.OB - news)
Related News Categories: health care, internet, medical/pharmaceutical